(Q54703493)

3 June 2018

title

Expression and mutation analysis of her2 in head and neck squamous cell carcinoma. (English)

1 reference

3 June 2018

author name string

Mahmoud A L Sheikh Ali

1 reference

3 June 2018

Mehmet Gunduz

1 reference

3 June 2018

Esra Gunduz

1 reference

3 June 2018

Ryo Tamamura

1 reference

3 June 2018

Levent Bekir Beder

1 reference

3 June 2018

Naoki Katase

1 reference

3 June 2018

Omer Faruk Hatipoglu

1 reference

3 June 2018

Kunihiro Fukushima

1 reference

3 June 2018

Noboru Yamanaka

1 reference

3 June 2018

Kenji Shimizu

1 reference

3 June 2018

Hitoshi Nagatsuka

1 reference

3 June 2018

publication date

1 June 2010

1 reference

3 June 2018

published in

Cancer Investigation

1 reference

3 June 2018

volume

1 reference

3 June 2018

issue

1 reference

3 June 2018

page(s)

495-500

1 reference

3 June 2018

Global cancer statistics, 2002

cites work

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

The ErbB-2/HER2 oncoprotein of human carcinomas may function solely as a shared coreceptor for multiple stroma-derived growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Expression and mutation analysis of epidermal growth factor receptor in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Mutational analysis of the HER2 gene in lung tumors from Caucasian patients: mutations are mainly present in adenocarcinomas with bronchioloalveolar features

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Allelic loss and reduced expression of the ING3, a candidate tumor suppressor gene at 7q31, in human head and neck cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

HER2 overexpression increases sensitivity to gefitinib, an epidermal growth factor receptor tyrosine kinase inhibitor, through inhibition of HER2/HER3 heterodimer formation in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Prognostic impact of HER-2/neu expression on squamous head and neck carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Role of HER2/neu in tumor progression and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Pharmacodiagnostic value of the HER family in head and neck squamous cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

Signaling via ErbB2 and ErbB3 associates with resistance and epidermal growth factor receptor (EGFR) amplification with sensitivity to EGFR inhibitor gefitinib in head and neck squamous cell carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900903476778

10.3109/07357900903476778

21 January 2018

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018